| Literature DB >> 34845074 |
Jane Noyes1, Gareth Roberts2, Gail Williams3, James Chess4, Leah Mc Laughlin5.
Abstract
OBJECTIVES: To explore how people with chronic kidney disease who are pre-dialysis, family members and healthcare professionals together navigate common shared decision-making processes and to assess how this impacts future treatment choice.Entities:
Keywords: adult nephrology; chronic renal failure; dialysis; end stage renal failure; qualitative research
Mesh:
Year: 2021 PMID: 34845074 PMCID: PMC8634024 DOI: 10.1136/bmjopen-2021-053937
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Three-talk model of shared decision-making adapted for pre-dialysis decision making.
Participant demographics and treatment decision table
| Total number of participants | n=56 | Total number of patients | n=37 |
| Female | n=30 | Female | n=17 |
| Male | n=26 | Male | n=20 |
| Patients chosen treatment | |||
| UHD | n=16 | ||
| HHD | n=9 | ||
| Age group | CAPD | n=5 | |
| n=2 | APD | n=4 | |
| n=3 | Conservative management | n=1 | |
| n=8 | Undecided | n=2 | |
| n=9 | |||
| n=19 | Time on current kidney replacement treatment | ||
| n=14 | Not started | n=23 (1 conservative management) | |
| n=1 | Under 1 year | n=8 | |
| 1–3 years | n=5 | ||
| Highest qualification | |||
| n=9 | Kidney service | ||
| n=11 | Cardiff | n=17 | |
| n=7 | Swansea | n=7 | |
| n=13 | Bangor | n=2 | |
| n=1 | Glan Clwyd | n=5 | |
| n=5 | Wrexham | n=6 | |
| Income | Total number of family members | n=19 | |
| n=21 | Female | n=13 | |
| n=22 | Male | n=6 | |
| n=13 | |||
| n=1 | |||
| Ethnicity | |||
| Welsh/English/Scottish/Northern Irish/British | n=56 | ||
| Area of deprivation* | |||
| n=12 | |||
| n=5 | |||
| n=7 | |||
| n=5 | |||
| n=8 |
*Overall score taken from Welsh Index of Multiple deprivation an online resource to estimate deprivation based on income, employment, Health, Education, Access to Services, Community Safety, Physical Environment and housing https://wimd.gov.wales/?_ga=2.206133845.791407745.1630500908–977393655.1630500908.
APD, Automated peritoneal dialysis; CAPD, Continuous ambulatory peritoneal dialysis; HHD, home haemodialysis; UHD, Unit-based dialysis.
Further details of people with CKD and family members’ interview selection and processes
| Topic guides | Topic guides were informed by the ‘three-talk’ model and were piloted during initial interviews with PPI involvement. Topic guides were created for people with CKD, family members as well as options for dialysis and included specific probes to help unpack why patients and family members had chosen a specific treatment over and above another treatment. When both people with CKD and family members were interviewed together, specific questions relevant for the family were posed to them and vice versa to help unpick where views and experiences were different and potentially influencing decisions ( |
| Interviewees | Interviews were undertaken by male and female researchers with relevant Doctorates who were experienced in interviewing and employed to work on the study. Interviewers had no prior relationship with patients or family members. Some of the professionals were known to one researcher. |
| Number of interviews | 37 interviews covering 37 individual patient cases, with a mix of one to one with patients, family members and joint interviews with patients and their spouse/partner. |
| Length of interviews | Semistructured between 30 min and 90 min. Participants were interviewed once. |
| Reasons for decline | Most people who were contacted consented to an interview with some declining due to time available to interview, recent bereavement or health issues. We also were contacted by more people than we had capacity to interview and used a theoretical sampling frame to construct a maximum variation sample. |
CKD, chronic kidney disease; PPI, patient and public involvement.
Professional interviews further details
| Topic guide | |
| Location | Place of work for healthcare professionals to fit in with clinical commitments and existing meeting schedules, whereby professionals met in clusters. |
| Number of interviews | Four semistructured interviews individually, two small group interviews with professionals in the same role (eg, consultants, pre-dialysis nurses) and three whole team focus groups. |
PPI, patient and public involvement.
Logic model of stages, moderators and outcomes of getting onto a home therapy
|
|
|
|
|
| |
| Stage 1 | Person with CKD is assessed by nephrologist as requiring treatment | Family and/or caregivers fully involved | Limited consultation time and/or opportunity | Patient and families understand the clinical need for treatment | Patient and families empowered by a good understanding of their health condition and future prognosis |
| Over time and appropriately, clinicians prepare patient and families for the future. | Patient and families are not informed of or does not understand consequences of no treatment or delays in treatment | ||||
| Stage 2 | Person provided with information about options (SDM education package) | Family and/or caregivers fully involved | Patient and families engaged, empowered and understands options including home therapy options | Patient and families are equipped to make an informed treatment choice | |
| Appropriate resources available (staff time, accessibility of clinics, travel time for home visits) | Late referral or sudden deterioration requires hurried decision-making (NICE guidance is 1 year in advance) | ||||
| Good relationship between patient, family members and whole MDT members | MDTs have poor understanding of treatment options and options that comorbidities allow | ||||
| Patient and family members have some pre-existing knowledge of chronic kidney disease and treatment options (may also be negative) | Patient and family have poor understanding or acceptance of their condition. Prognosis (including death) not discussed | ||||
| Clinicians have high communication skills, so that person’s preference for information is discussed (eg, amount and format) | Clinicians may have their own agenda, for example, may be pressed for time to get through patient cases. | ||||
| Mix of informal and formal approaches | Bias (overt or unconscious) towards particular therapies in education literature and/or face-to-face sessions | ||||
| Personalised education provided that empowers people and supports self-care. | Patient and family members suffer from information ‘overload’ | ||||
| Information delivered consistently, in a range of formats. | Prior knowledge informs heuristic decision-making | ||||
| Consistent peer-delivered information, updated and reviewed | Caregivers and/or family not fully involved or have their own needs and concerns, which impact on decision-making | ||||
| Equipoise achieved (making the correct range of options available and listing them in a logical sequence and in sufficient clarity, so that people perceive the opportunity to take part in the decision) | Ideas, concerns and expectations of person (and family/caregivers) not fully addressed | ||||
| Stage 3 | Patient and families deliberate and express choice of dialysis modality | Presumption of home therapies as the norm | ‘Abandonment’—professionals offer information about choices but no guidance | Patient makes a choice supported by their family/caregivers | Patient (who is deemed medically suitable) chooses a home therapy (if not appropriate, they move to a different pathway) |
| Positive image of home therapies | Patient is unable to make a decision and defers to 'experts' | ||||
| Patient and families’ cognitive abilities are accounted for in supporting decisions—including home therapies | Negative psychological factors of home therapy, for example, fear and anxiety | ||||
| Patient and families have positive exposure to other home therapy patients and their family/caregivers | Unmet social care issues (eg, housing, welfare benefits, social isolation) prevent home therapies being considered by either patient, families or professionals | ||||
| Patient and family have a supportive and suitable home environment | Because patient may not feel unwell, they maintain previous behaviour and avoid making decisions | ||||
| Decision is made or negotiated in partnership with patients, family and health and social care professionals | Language, terminology and complexity of options affect decision-making capabilities of person | ||||
| Fewer options lead to easier decision-making | Medical efficacy of treatment options not considered by patient | ||||
| Stage 4 | Consideration by Clinical team (with social care input) incorporating the preferences of patient and families. | MDTs work with social care and voluntary agencies work together to overcome non-clinical barriers to home therapies | MDT resource and time constraints | MDT decision to support patient with a home therapy | Patient and family are supported by the whole MDT team in their choice of an appropriate home therapy |
| Health and social care professionals’ work together to overcome social barriers to home therapy | Risk aversion by health professionals | ||||
| All MDTs are well trained and knowledgeable about home therapies | Clinician bias against patient attributes, for example, social situation, learning disability or frailty | ||||
| Impact of alternative decisions with regards to the values and lifestyles of person with CKD fully considered | Clinician bias towards certain therapies | ||||
| Stage 5 | Joint decision made of dialysis modality | Settlements and/or compromises reached through shared decision-making. | Delays to decision | Patient, families and professionals recognise that a good decision has been made. | Patient and families are ready to be prepared for a home therapy |
| Option open to review decision in the future | Restricted opportunities for home therapy training or poor quality training | ||||
| Action plan agreed and arrangements made for follow-up | Changing health and social circumstances | ||||
| Stage 6 | Patient and families are prepared for kidney replacement therapy | Preparation, and commencement of, home dialysis happens speedily | Patient may change their mind | Home therapy is facilitated | Patient embarks on a home therapy |
| Positive and timely communication with patient and families. | Poor coordination between agencies (eg, health and social care) in facilitating home dialysis. | ||||
| Ongoing, coordinated health and care support for patient and families | |||||
CKD, chronic kidney disease; MDT, Multi-disciplinary team; NICE, National Institute for Health and Care Excellence; SDM, shared decision-making.
Road map and recommendations for service delivery change to increase uptake of home dialysis
| 1. | A presumption of home therapies through the clinical pathway adopted by all, including consultants, nurses, other members of MDT, managers and commissioners, and reflected in education. |
| 2. | ‘Early’ education for people with CKD and families. Talking to people about dialysis too early may lead to unnecessary anxiety, particularly for many patients who will never require dialysis, but ‘early’ education can focus on the basics of kidney disease, the consequences of CKD (even mild/moderate kidney disease), the importance of blood pressure control, smoking cessation, weight loss, etc. For some people with clearly progressive kidney disease (eg, young patients with polycystic kidneys or type 1 diabetes) who need dialysis and transplant information at earlier eGFR blood tests, early education would help them come to terms with treatment and early-identify barriers to home therapy. This would also assist in patient activation and engagement (see below). |
| 3. | Redesign education packages. so that patients rely less on unreliable or industry-sponsored resources. This is likely to be a mixture of online material, group discussion (delivered by peers where possible) and one-to-one sessions. All MDTs have a key role in identifying which education package is best suited for each patient, but the content should be standardised regardless of how or who delivers it. Education packages should also fully engage the family in recognition of their crucial role in decision-making. |
| 4. | Encourage patient engagement and activation at an early stage rather than wait until the time of decision-making and then expecting people to become active in their own care. For example, two-way patient portals, which both deliver education/information updates/patient results/clinic letters to the patient and also let the patient upload information, which is important to their care (eg, blood pressure/weight/key symptoms) and viewed by patients. |
| 5. | Update knowledge of home therapies to ensure that clinicians and all kidney MDT members have the in-depth and up-to-date knowledge needed to discuss options in detail with patients and family members. |
| 6. | Move away from purely medical/results focus. Shared decision-making requires a holistic understanding of the patient and family members’ needs—their social circumstances, support networks, their values and preferences as well as their medical needs. Clinicians often have a disease-focused model of history-taking, so that understanding of the patient is based mainly on blood results and comorbidity, and treatment choices may be based on clinical outcomes (such as survival). An appropriate clinic template, sufficient clinic time and training for MDTs would be important in delivering change. |
| 7. | Social and psychological support. A high burden of anxiety (and likely depression) that is unrecognised by clinical teams will impact on decision-making. There are tools that clinicians could use to aid in identifying these symptoms (eg, validated questionnaires); they need to draw on specialist kidney social work and psychologist capacity; and be able to sign-post to appropriate external support. |
CKD, chronic kidney disease; eGFR, Estimated Glomeruler Filtration Rate; MDT, Multi-disciplinary team.